Forecasting and Ordering. 2.1 Sativex BDP will be ordered by Novartis against a rolling forecast, with details of firm order periods and other related matters to be contained in the Manufacturing and Supply Agreement. 2.2 In addition, Novartis will have the ability to request GW to provide Additional Services from time to time. The fee for providing Additional Services will be agreed on a case by case basis.
Appears in 3 contracts
Sources: Distribution and License Agreement (Gw Pharmaceuticals PLC), Distribution and License Agreement (Gw Pharmaceuticals PLC), Distribution and License Agreement (Gw Pharmaceuticals PLC)